Editorial – Page 6 – ExecEdge

Vaxxinity, UF Join Forces Against Neurodegenerative Diseases

Vaxxinity, UF Join Forces Against Neurodegenerative Diseases

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it’s with the University of Florida’s Center for Translational Research in Neurodegenerative Disease (CTRND) to develop vaccines for diseases like Alzheimer’s and Parkinson’s. The collaboration aims to understand and neutralize toxic brain...

Sirnaomics Publishes Research on Cancer Drug Candidate

Sirnaomics Publishes Research on Cancer Drug Candidate

By Karen E. Roman Sirnaomics Ltd., a biopharmaceutical company developing RNAi therapeutics, recently published a research article showing a cancer drug candidate to treat solid tumors. The article focused on the company’s clinical studies with STP707, a polypeptide nanoparticle  formulation,...

Tonix Study Reveals Promising Fibromyalgia Treatment

Tonix Study Reveals Promising Fibromyalgia Treatment

By Daniella Parra Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) said it showed additional safety and tolerability data, marking the second positive Phase 3 study assessing TNX-102 SL for fibromyalgia management. Tonix said the study met its primary endpoint, demonstrating statistically...

Vaxxinity & UCF to Collaborate on Space Medicine Research

Vaxxinity & UCF to Collaborate on Space Medicine Research

By Karen E. Roman Vaxxinity, Inc. (NASDAQ: VAXX) said it will collaborate with the University of Central Florida in the advancement of space medicine research through a grant funded by the state of Florida. The goal is to further develop...

Input your search keywords and press Enter.